Emerging Infectious Diseases (May 2022)

Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017

  • Gisele Peirano,
  • Liang Chen,
  • Diego Nobrega,
  • Thomas J. Finn,
  • Barry N. Kreiswirth,
  • Rebekah DeVinney,
  • Johann D.D. Pitout

DOI
https://doi.org/10.3201/eid2805.212535
Journal volume & issue
Vol. 28, no. 5
pp. 924 – 931

Abstract

Read online

We describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance.

Keywords